Survey of the rate of PSA testing in general practice.
The use of prostate specific antigen (PSA) test could have a large impact on the incidence of prostate cancer in the UK. Over a period of 1 year (1999), 3.5% out of 160 015 men aged > 45 on a GP database, who had no previous record of prostate cancer, had a PSA test. Of the tested men, 21.3% had a PSA > 4 ng/ml. Future data need to distinguish between men with and without symptoms.
Melia
J
J
Cancer Screening Evaluation Unit, Institute of Cancer Research, Section of Epidemiology, D Block, Cotswold Road, Sutton, Surrey, SM2 5NG, UK.
Moss
S
S
D017677:Age Distribution; D000368:Aged; D005194:Family Practice / Q000706:statistics & numerical data; D019538:Health Care Surveys / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000032:analysis*; D012189:Retrospective Studies
D017430:Prostate-Specific Antigen